CLINICAL_TRIALS
trial_result
· 2022-11-10
Clinical Trial Update: A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack [Phase 2]
Summary
A Phase 2 study evaluating the usability of the Needle-free Intraject system in adults during an acute migraine attack has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zogenix, Inc. | Conditions: Migraine Headache | Phase 2 | Status: COMPLETED